PTGX
Protagonist Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$145.11
−2.48%Margins
Gross margin
99.9%
EBITDA margin
30.3%
EBIT margin
20.7%
Net margin
29.4%
FCF margin
46.9%
9.9%
Return on equity
9.4%
Return on assets
6.9%
Return on invested capital
0.36x
Asset turnover
$131.2M
Cash from operations
$12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026